Phase
Condition
Urothelial Carcinoma
Carcinoma
Treatment
18F-FDG
Clinical Study ID
Ages 18-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18-75 years old, male or female;
Heart function is normal;
Normal heart function;
Estimated survival ≥12 weeks;
Good follow-up compliance;
presence of at least one measurable target lesion according to RECIST1.1 criteria;
Women of childbearing age (15-49 years) must have a negative pregnancy test within 7days before starting the test; Fertile men and women must agree to use effectivecontraception to prevent pregnancy during the study period and for 3 months afterthe test;
Patients recommended by clinicians to undergo PET/CT examination for tumordiagnostic staging;
The subject patients could fully understand and voluntarily participate in theexperiment, and signed the informed consent.
Exclusion
Exclusion Criteria:
Serious abnormality of liver, kidney and blood;
Pregnant patients;
Pregnant and lactation women;
- unable to lie flat for half an hour; 4) Refuse to join the clinical investigator; 5)Suffering from claustrophobia or other mental diseases; 6) Other conditions thatresearchers deem unsuitable for participating in the experiment.
Study Design
Connect with a study center
Beijing Cancer Hospital
Beijing, Beijing 100142
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.